JP2019505565A5 - - Google Patents

Info

Publication number

JP2019505565A5

JP2019505565A5 JP2018546726A JP2018546726A JP2019505565A5 JP 2019505565 A5 JP2019505565 A5 JP 2019505565A5 JP 2018546726 A JP2018546726 A JP 2018546726A JP 2018546726 A JP2018546726 A JP 2018546726A JP 2019505565 A5 JP2019505565 A5 JP 2019505565A5

Authority

JP

Japan

Prior art keywords

tyr

leu

lys

trp

ser

Prior art date

2016-11-30

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 229920001184 polypeptide Polymers 0.000 claims description 31
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 31
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 31
• 230000004927 fusion Effects 0.000 claims description 24
• 150000001413 amino acids Chemical class 0.000 claims description 18
• 102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 claims description 15
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims description 15
• 239000000427 antigen Substances 0.000 claims description 14
• 102000036639 antigens Human genes 0.000 claims description 14
• 108091007433 antigens Proteins 0.000 claims description 14
• 239000012634 fragment Substances 0.000 claims description 13
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 12
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 9
• 125000000539 amino acid group Chemical group 0.000 claims description 7
• 238000006467 substitution reaction Methods 0.000 claims description 6
• 239000000203 mixture Substances 0.000 claims description 4
• 102000013382 Gelatinases Human genes 0.000 claims description 2
• 108010026132 Gelatinases Proteins 0.000 claims description 2
• 102000019298 Lipocalin Human genes 0.000 claims description 2
• 108050006654 Lipocalin Proteins 0.000 claims description 2
• 229960000397 bevacizumab Drugs 0.000 claims description 2
• 102000037865 fusion proteins Human genes 0.000 claims 26
• 108020001507 fusion proteins Proteins 0.000 claims 26
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
• 102000004169 proteins and genes Human genes 0.000 claims 4
• 108090000623 proteins and genes Proteins 0.000 claims 4
• 201000010099 disease Diseases 0.000 claims 3
• 230000033115 angiogenesis Effects 0.000 claims 2
• 208000035475 disorder Diseases 0.000 claims 2
• 230000002401 inhibitory effect Effects 0.000 claims 2
• 150000007523 nucleic acids Chemical class 0.000 claims 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
• 102000009075 Angiopoietin-2 Human genes 0.000 claims 1
• 108010048036 Angiopoietin-2 Proteins 0.000 claims 1
• 101100481408 Danio rerio tie2 gene Proteins 0.000 claims 1
• 101100481410 Mus musculus Tek gene Proteins 0.000 claims 1
• 206010028980 Neoplasm Diseases 0.000 claims 1
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
• 208000022873 Ocular disease Diseases 0.000 claims 1
• 201000004681 Psoriasis Diseases 0.000 claims 1
• 206010003246 arthritis Diseases 0.000 claims 1
• 230000008827 biological function Effects 0.000 claims 1
• 201000011510 cancer Diseases 0.000 claims 1
• 230000004663 cell proliferation Effects 0.000 claims 1
• 208000015181 infectious disease Diseases 0.000 claims 1
• 208000027866 inflammatory disease Diseases 0.000 claims 1
• 238000000034 method Methods 0.000 claims 1
• 230000035772 mutation Effects 0.000 claims 1
• 108020004707 nucleic acids Proteins 0.000 claims 1
• 102000039446 nucleic acids Human genes 0.000 claims 1
• 239000002773 nucleotide Substances 0.000 claims 1
• 125000003729 nucleotide group Chemical group 0.000 claims 1
• 239000008194 pharmaceutical composition Substances 0.000 claims 1
• 230000002265 prevention Effects 0.000 claims 1
• 230000004614 tumor growth Effects 0.000 claims 1
• 208000019553 vascular disease Diseases 0.000 claims 1
• 235000001014 amino acid Nutrition 0.000 description 14
• 108060003951 Immunoglobulin Proteins 0.000 description 2
• 239000000539 dimer Substances 0.000 description 2
• 102000018358 immunoglobulin Human genes 0.000 description 2
• 108020004705 Codon Proteins 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
• 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 210000000440 neutrophil Anatomy 0.000 description 1
• 230000013777 protein digestion Effects 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1